MASLD and HBV: How Concurrence May Paradoxically Protect and Worsen Disease

The prevalence of fatty liver disease has increased worldwide, and is particularly problematic among patients with ...

SEPTEMBER 11, 2024

HCV Elimination Program So Successful, Country of Georgia Tackles HBV

Program could serve as a model for others to tackle these viral diseases.

SEPTEMBER 6, 2024

‘Viral Hepatitis Is Not Gone—Not Yet’

About 1.2 million people around the world are infected with hepatitis B each year; the U.S. sees about 20,000 new ...

AUGUST 26, 2024

Protecting More Adults From HBV

With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against ...

JULY 19, 2023

Hepatitis B Vaccine Shows Low Seroconversion in Liver Transplant Patients

Less than half of liver transplant candidates given a new recombinant hepatitis B vaccine showed seroconversion ...

OCTOBER 31, 2022

2-Dose Hepatitis B Vaccine More Seroprotective, Cost-Effective

Administration of the two-dose adjuvanted hepatitis B virus vaccine may be cost-effective in many of the adults ...

OCTOBER 22, 2021

How Durable Is the Hepatitis B Vaccine?

Washington—About 85% of a cohort of Alaskans who received the hepatitis B vaccine at age 6 months or older ...

MAY 31, 2018